BG43692A3 - Method for preparing of 6, 16- dimethylcorticoids - Google Patents

Method for preparing of 6, 16- dimethylcorticoids

Info

Publication number
BG43692A3
BG43692A3 BG067461A BG6746183A BG43692A3 BG 43692 A3 BG43692 A3 BG 43692A3 BG 067461 A BG067461 A BG 067461A BG 6746183 A BG6746183 A BG 6746183A BG 43692 A3 BG43692 A3 BG 43692A3
Authority
BG
Bulgaria
Prior art keywords
dimethylcorticoids
preparing
new
production
side effects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
BG067461A
Other languages
Bulgarian (bg)
English (en)
Inventor
Klaus Annen
Henry Laurent
Helmut Hofmeister
Rudolf Wiechert
Michael Toepert
Hans Wendt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Schering Pharma AG
Original Assignee
Bayer Schering Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma AG filed Critical Bayer Schering Pharma AG
Publication of BG43692A3 publication Critical patent/BG43692A3/xx
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
BG067461A 1982-07-19 1983-07-18 Method for preparing of 6, 16- dimethylcorticoids Expired BG43692A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3227312A DE3227312A1 (de) 1982-07-19 1982-07-19 Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
BG43692A3 true BG43692A3 (en) 1988-07-15

Family

ID=6168986

Family Applications (2)

Application Number Title Priority Date Filing Date
BG061781A BG43693A3 (en) 1982-07-19 1983-07-18 Method for preparing of 6, 16- dimethylcorticoids
BG067461A Expired BG43692A3 (en) 1982-07-19 1983-07-18 Method for preparing of 6, 16- dimethylcorticoids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG061781A BG43693A3 (en) 1982-07-19 1983-07-18 Method for preparing of 6, 16- dimethylcorticoids

Country Status (23)

Country Link
US (2) US4555507A (fr)
EP (1) EP0100874B1 (fr)
JP (1) JPS5967298A (fr)
AT (1) ATE50780T1 (fr)
AU (1) AU1694183A (fr)
BG (2) BG43693A3 (fr)
CA (1) CA1312856C (fr)
DD (1) DD214134A5 (fr)
DE (2) DE3227312A1 (fr)
DK (1) DK162232C (fr)
ES (1) ES524238A0 (fr)
FI (1) FI832575A (fr)
GB (1) GB2124230A (fr)
GR (1) GR78902B (fr)
HU (1) HU191539B (fr)
IE (1) IE55771B1 (fr)
IL (1) IL69230A (fr)
NO (1) NO157453C (fr)
PH (1) PH19976A (fr)
PL (1) PL141537B1 (fr)
PT (1) PT76995B (fr)
RO (4) RO92853B1 (fr)
ZA (1) ZA835249B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
DE3400188A1 (de) * 1984-01-02 1985-07-11 Schering AG, Berlin und Bergkamen, 1000 Berlin Neue 6(alpha),16(alpha)-dimethylkortikoide
DE3401680A1 (de) * 1984-01-16 1985-07-18 Schering AG, 1000 Berlin und 4709 Bergkamen 6(alpha),16ss-dimethylkortikoide
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
US5319115A (en) * 1987-08-25 1994-06-07 Cocensys Inc. Method for making 3α-hydroxy, 3β-substituted-pregnanes
US4866050A (en) * 1988-04-27 1989-09-12 Ben Amoz Daniel Ultrasonic transdermal application of steroid compositions
DE3915951C1 (fr) * 1989-05-12 1990-09-13 Schering Ag, 1000 Berlin Und 4709 Bergkamen, De
AU7556291A (en) * 1990-03-27 1991-10-21 Schering Corporation Process for 9alpha-hydroxy steroid dehydration
FR2701262B1 (fr) * 1993-02-05 1995-03-24 Roussel Uclaf Nouveau procédé de préparation de stéroïdes 6 alpa, 9 alpha-difluorés et nouveaus intermédiaires.
DE4333920A1 (de) * 1993-10-05 1995-04-13 Hoechst Ag Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US5502222A (en) * 1994-06-01 1996-03-26 Schering Corporation Process for preparing delta 9,11 and 21-chloro corticosteroids
ES2744879T3 (es) 2008-05-28 2020-02-26 Reveragen Biopharma Inc Moduladores esteroideos no hormonales de NF-kappaB para el tratamiento de enfermedades
WO2011127048A2 (fr) 2010-04-05 2011-10-13 Validus Biopharma MODULATEURS STÉROÏDES NON HORMONAUX DE NF-ĸB POUR LE TRAITEMENT DE MALADIES
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU75903A1 (fr) * 1976-09-29 1978-05-16
GB931224A (en) * 1958-10-01 1963-07-17 Merck & Co Inc Steroid compounds and their production
GB898295A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
GB898292A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
CH429716A (de) * 1961-06-24 1967-02-15 Vismara Francesco Spa Verfahren zur Herstellung von 17a-Acyloxy-21-hydroxy-Steroiden
US3054811A (en) * 1961-09-14 1962-09-18 Merck & Co Inc Ring a unsaturated 6, 16-dimethyl steroids of the pregnane series
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
GB1047519A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡,21-diesters of 11,17,21-trihydroxy steroid compounds
GB1544642A (en) * 1976-06-04 1979-04-25 Bristol Myers Co 9,11-epoxy steroids and synthesis of corticosteroids therefrom
DE2645105C2 (de) * 1976-10-04 1986-03-13 Schering AG, 1000 Berlin und 4709 Bergkamen Derivate des 9-Chlorprednisolons, Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Präparat
DE2715854A1 (de) * 1977-04-06 1978-10-19 Schering Ag Verfahren zur herstellung von 11alpha,21-dihydroxy-1,4-pregnadien- 3,20-dion-derivaten
US4086254A (en) * 1977-04-13 1978-04-25 The Upjohn Company Photocleavable steroids
DE2759135A1 (de) * 1977-12-30 1979-07-19 Lark Spa Neue steroidverbindungen und deren herstellung und verwendung
US4154748A (en) * 1978-01-20 1979-05-15 The Upjohn Company Phosphate catalyzed acylation of steroidal tertiary alcohols
DE2803661A1 (de) * 1978-01-25 1979-07-26 Schering Ag Neue in 17-position substituierte 11beta-hydroxysteroide der pregnanreihe, ihre herstellung und verwendung
DE2901561A1 (de) * 1979-01-12 1980-07-31 Schering Ag Verfahren zur herstellung von 11 beta, 17 alpha, 21-trihydroxy-4-pregnen-3,20dion-derivaten
DE3169460D1 (en) * 1980-12-23 1985-04-25 Schering Ag 6-alpha-methyl hydrocortisone derivatives, their preparation and their utilization
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung

Also Published As

Publication number Publication date
DE3227312A1 (de) 1984-01-19
FI832575A (fi) 1984-01-20
DD214134A5 (de) 1984-10-03
AU1694183A (en) 1984-01-26
FI832575A0 (fi) 1983-07-14
PL141537B1 (en) 1987-08-31
ES8403929A1 (es) 1984-04-16
DK162232B (da) 1991-09-30
EP0100874A3 (en) 1985-04-17
RO92853A2 (fr) 1987-11-30
JPH0415239B2 (fr) 1992-03-17
NO157453C (no) 1988-03-23
EP0100874B1 (fr) 1990-03-07
RO92855A (fr) 1987-11-30
ATE50780T1 (de) 1990-03-15
GB2124230A (en) 1984-02-15
US4701451A (en) 1987-10-20
PT76995B (de) 1986-01-09
BG43693A3 (en) 1988-07-15
HU191539B (en) 1987-03-30
EP0100874A2 (fr) 1984-02-22
DK329183D0 (da) 1983-07-18
RO92853B1 (ro) 1987-12-01
US4555507A (en) 1985-11-26
ES524238A0 (es) 1984-04-16
GB8319363D0 (en) 1983-08-17
RO92854A (fr) 1987-11-30
DK329183A (da) 1984-01-20
PH19976A (en) 1986-08-26
DE3381291D1 (de) 1990-04-12
IL69230A0 (en) 1983-11-30
IE55771B1 (en) 1991-01-16
CA1312856C (fr) 1993-01-19
GR78902B (fr) 1984-10-02
IL69230A (en) 1988-07-31
ZA835249B (en) 1984-03-28
PT76995A (de) 1983-08-01
NO157453B (no) 1987-12-14
PL243082A1 (en) 1984-11-19
DK162232C (da) 1992-03-02
NO832609L (no) 1984-01-20
IE831658L (en) 1984-01-19
RO92856A (fr) 1987-11-30
JPS5967298A (ja) 1984-04-16

Similar Documents

Publication Publication Date Title
BG47033A3 (en) Method for preparing of derivatives of imidazolamine
BG49825A3 (en) Method for preparing of 10- dihydro- 10- deoxo- 11- asaeritronolides a
BG43692A3 (en) Method for preparing of 6, 16- dimethylcorticoids
IE39078B1 (en) New 1-phenyl-substituted 1,3,5-triazines, their production and their medicinal use
ES8601236A1 (es) Un procedimiento para la preparacion de derivados peptidicos
BG41126A3 (en) Method for preparing benzamides
BG35042A3 (en) Method for preparing benzodiazepinic compounds
AR204951A1 (es) Procedimiento para la produccion de nuevas pirazolonas-(5)1-substituidas
FR2321294A1 (fr) Derives d'acides 7b-amino-3-cephem-3-carbonylmethyl-4-carboxyliques utiles comme medicaments
IT7948462A0 (it) Procedimento per la produzione diresine di chelati e prodotto ottenuto
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.
YU40105B (en) Process for the manufacture of n-arylsulfonyl-n'-(aza-3-bicycloalyl)-carbamides
BG43688A3 (en) Method for preparing of dl- beta- aryl- aminoacids
DE3466530D1 (de) 2,2-diethoxypropionic acid derivatives
BG35044A3 (en) Method for preparing 1- oxa- beta- lactamic antibiotics
BG38640A3 (en) Method for preparing n- arylsulphenyl- n- diaryloxy- phosphinylmethylglycinates
BG39977A3 (en) Method for preparing derivatives of furyloxazolylacetic acid
ES449895A1 (es) Procedimiento para preparar alcoxiacilaminofenilacetamidas.
ZA755310B (en) Process for the preparation of 9,11,15-trihydroxy-13, 14-dehydro-prostaglandins and new prost-5-en-13-ynoic acid derivatives
CA1028329A (fr) Sels amines et sels de sodium et mono de diesters de l'acide dihydroxy-2,5 benzene sulfonique
SU461750A1 (ru) Спсоб подготовки заготовок к прессованию
ES2001042A6 (es) Un metodo para la preparacion de acidos 5,6-dialcoxiantranilicos
PT70367A (en) Process for the preparation of 4,4-dimethyl-4-sila-fatty acid amides with pharmaceutical effect
IT1117196B (it) Procedimento per la produzione di amminoantrachinone e prodotto ottenuto
BG44031A3 (en) Method for preparing of cephalosporines